Qiagen NV | QIA - Interest Income


Qiagen NV reported $10.56M in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
argenx SE USD 44M 874K Mar/2026
Dianthus Therapeutics USD 6.26M 2.61M Mar/2026
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
IQVIA Holdings USD 10M 1000K Mar/2026
Moderna USD 70M 3M Dec/2025
Qiagen NV USD 10.56M 9.44M Mar/2026
Revvity USD 5.75M 5.75M Dec/2025
Tectonic Therapeutic USD 1.74M 217K Dec/2024
Xeris Pharmaceuticals USD 1.2M 44K Mar/2026